LATEST EVIDENCE OF NUTRITION SUPPLEMENTATION IN LEAN BODY MASS, HEALTH, AND RECOVERY

ASPEN CNW 2017, Orlando, Florida, USA
Why You Can’t Afford to Ignore Malnutrition: New Health Economics Study

Scott Goates, PhD
Abbott Nutrition Research and Development
Columbus, OH, USA

Dr. Goates describes a health economics and outcomes research (HEOR) analysis of estimated lifetime data from the multicenter, randomized, placebo-controlled clinical trial of oral nutritional supplementation with high protein and β-hydroxy-β-methylbutyrate (HP-HMB) in malnourished, cardiopulmonary patients aged 65 years or older (The NOURISH Study†). Careful modeling of healthcare costs and benefits indicates that the HP-HMB intervention 1) increased projected life expectancy by 8.5 months, 2) had a Number Needed to Treat (NNT) of 20.3 to prevent one death, and 3) had a 10x lower Cost per Quality Adjusted Life Year (QALY) than aspirin.

† NOURISH = Nutrition effect On Unplanned ReadmIssions and Survival in Hospitalized patients

Why You Can’t Afford to Ignore Malnutrition: New Health Economics Study
Why You Can’t Afford to Ignore Malnutrition: New Health Economics Study
Scott Goates, PhD

Additional Recommended Content

Differences in resource utilization between patients with diabetes receiving glycemia-targeted specialized nutrition vs standard nutrition formulas in U.S. hospitals.
Osama Hamdy, MD, PhD ; Frank R. Ernst, PharmD, MS ; Dorothy Baumer, MS ; Vikkie Mustad, PhD ; Jamie Partridge, PhD, MBA ; and Refa...

*at no charge